Topic: Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong Speaker: Dr. Daniel Lee, Associate Vice-President (Innovation and Enterprise), The Chinese University of Hong Kong Language: English Target […]
On December 18, 2019, around 70 members from the regulatory affairs and pharmacovigilance department attended the New Product submission and Best Practice Workshop held at HKU.
About 60 members, non-members and academics turned up for Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop jointly organized by The University of Hong Kong and HKAPI.
On 30 April 2019, the Regulatory Affairs Taskforce (RATF) presented a sharing session to update members on the latest achievements and work in progress in relation to the various regulatory affairs initiatives.
On 14 December 2018, a joint briefing session between the Drug Office and HKAPI was held at the Public Health Laboratory Centre in Kowloon. It was overwhelmingly attended by about 90 members, with the majority being Regulatory Affairs staff.
85 members, non-members and academics turned up for Regulatory Training Programme Course 4 – the last core course of the Programme which is jointly organized by The University of Hong Kong and HKAPI.